Skip to main content

Advertisement

Log in

Oncologic Status of Obturator Lymph Node Metastases in Locally Advanced Low Rectal Cancer: A Japanese Multi-Institutional Study of 3487 Patients

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The American Joint Committee on Cancer tumor-node-metastasis staging system for rectal cancer defines lateral pelvic lymph nodes (LPLNs) only in the internal iliac region as regional. However, the Japanese Society for Cancer of the Colon and Rectum (JSCCR) staging system, also considers obturator lymph nodes (LNs) as regional. This retrospective cohort study evaluated the oncologic status of obturator LNs in low rectal cancer.

Methods

The study identified 3487 patients with pT3-T4 low rectal cancer who had undergone curative resections without preoperative radiotherapy or chemotherapy between 2003 and 2011 in the JSCCR database and divided them into six groups. Overall survival (OS) and recurrence-free survival (RFS) were analyzed by groups.

Results

Histologic LPLN metastases were identified in 8% (279/3487) of all the patients and in 18.2% (279/1530) of the patients who underwent lateral pelvic node dissection. The 5-year OS and RFS rates of the obturator-LPLN group (P = 0.095) were worse than those of the internal-LPLN group (P = 0.075), but the difference was not significant. The OS of the obturator-LPLN group was similar to that of the resectable liver metastasis group (P = 0.731), and the RFS of the obturator-LPLN group was significantly better than that of the other-LPLN group (P = 0.016).

Conclusion

The prognosis for obturator LN metastases in low rectal cancer was not significantly worse than for internal iliac LN metastases, defined as regional by the current American Joint Committee on Cancer staging system, and the oncologic status of obturator LNs warrants more studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease. Ann Surg. 2012;255:1129–34.

    Article  Google Scholar 

  2. JSCCR. Japanese classification of colorectal, appendiceal, and anal carcinoma: the 3rd English edition secondary publication. J Anus Rectum Colon. 2019;3(10):175–950.

    Google Scholar 

  3. Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th edn. Chicago, IL: American College of Surgeons; 2018.

    Google Scholar 

  4. Roels S, Duthoy W, Haustermans K, et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys. 2006;65:1129–42.

    Article  Google Scholar 

  5. Hashiguchi Y, Muro K, Saito Y, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1–42.

    Article  Google Scholar 

  6. Ouchi Y, Rakugi H, Arai H, et al. Redefining the elderly as aged 75 years and older: proposal from the Joint Committee of Japan Gerontological Society and the Japan Geriatrics Society. Geriatr Gerontol Int 2017;17:1045–7.

    Article  Google Scholar 

  7. Chen CH, Hsieh MC, Hsiao PK, Lin EK, Lu YJ, Wu SY. A critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinoma. J Cancer. 2017;8:1927–34.

    Article  Google Scholar 

  8. The lymph node committee of JSCCR. Record of proceedings. http://mail.jsccr.jp/committee/pdf/lymph/proj_lymph201606.pdf.

  9. JSCCR. Japanese classification of colorectal, appendiceal, and anal carcinoma. 2nd edn. Tokyo: Kanehara & Co Ltd; 2009.

    Google Scholar 

  10. Ogura A, Konishi T, Beets GL, Cunningham C, Garcia-Aguilar J, Iversen H, et al. Lateral nodal features on restaging magnetic resonance imaging associated with lateral local recurrence in low rectal cancer after neoadjuvant chemoradiotherapy or radiotherapy. JAMA Surg. 2019;154:e192172.

    Article  Google Scholar 

  11. Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th edn. Oxford, UK: John Wiley & Sons; 2017.

    Google Scholar 

  12. Edge S, Compton CC, Fritz AG, et al. AJCC cancer staging manual. 7th edn. New York, NY: Springer; 2010.

    Google Scholar 

  13. Benson AB, Venook AP, Al-Hawary MM, et al. Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16:874–901.

    Article  Google Scholar 

  14. Ishihara S, Kawai K, Tanaka T, et al. Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Dis Colon Rectum. 2017;60:469–76.

    Article  Google Scholar 

  15. Wo JY, Anker CJ, Ashman JB, et al. Radiation therapy for rectal cancer: executive summary of an ASTRO clinical practice guideline. Pract Radiat Oncol. 2021;11:13–25.

    Article  Google Scholar 

  16. Kanemitsu Y, Komori K, Shida D, et al. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: a comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Surgery. 2017;162:303–14.

    Article  Google Scholar 

  17. Ogura A, Konishi T, Cunningham C, et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol. 2019;37:33–43.

    Article  CAS  Google Scholar 

  18. Watanabe T, Ishihara S. Management of lateral pelvic lymph nodes: rectal cancer. 1st edn. Cham, Switzerland: Springer; 2018.

    Google Scholar 

  19. Inoue H, Sasaki K, Nozawa H, et al. Therapeutic significance of D3 dissection for low rectal cancer: a comparison of dissections between the lateral pelvic lymph nodes and the lymph nodes along the root of the inferior mesenteric artery in a multicenter retrospective cohort study. Int J Colorectal Dis. 2021;36:1263–70.

    Article  Google Scholar 

  20. Ueno M, Oya M, Azekura K, et al. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg. 2005;92:756–63.

    Article  CAS  Google Scholar 

  21. Schaap DP, Boogerd L, Konishi T, Cunningham C, Ogura A, Garcia-Aguilar J, et al. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. Br J Surg. 2021;108:205–13.

    Article  CAS  Google Scholar 

  22. Viganò L, Langella S, Ferrero A, Russolillo N, Sperti E, Capussotti L. Colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes. Ann Surg Oncol. 2013;20:938–45.

    Article  Google Scholar 

  23. Tsukamoto S, Fujita S, Ota M, et al. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Br J Surg. 2020;107:586–94.

    Article  CAS  Google Scholar 

  24. Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009;10:1053–62.

    Article  Google Scholar 

  25. Wilson MK, Collyar D, Chingos DT, et al. Outcomes and end points in cancer trials: bridging the divide. Lancet Oncol. 2015;16:e43-52.

    Article  Google Scholar 

  26. Kim HJ, Choi GS, Park JS, et al. Selective lateral pelvic lymph node dissection: a comparative study of the robotic versus laparoscopic approach. Surg Endosc. 2018;32:2466–73.

    Article  Google Scholar 

  27. Kawai K, Hata K, Tanaka T, Nishikawa T, Otani K, Murono K, et al. Learning curve of robotic rectal surgery with lateral lymph node dissection: cumulative sum and multiple regression analyses. J Surg Educ. 2018;75:1598–605.

    Article  Google Scholar 

  28. Aiba T, Uehara K, Mukai T, et al. Transanal extended rectal surgery with lateral pelvic lymph node dissection. Tech Coloproctol. 2018;22:893–4.

    Article  CAS  Google Scholar 

  29. Masubuchi S, Okuda J, Hamamoto H, et al. Totally extraperitoneal approach to laparoscopic lateral lymph node dissection for patients with recurrent lateral pelvic lymph nodes after rectal cancer surgery: a novel technique-M TEP LLND. Surg Today. 2019;49:981–4.

    Article  Google Scholar 

  30. Sun Y, Zhang Z, Zhou Y, et al. Fascial space priority approach in laparoscopy: lateral pelvic lymph node dissection for advanced low rectal cancer. Tech Coloproctol. 2020;24:335–6.

    Article  CAS  Google Scholar 

  31. Yano H, Moran BJ. The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West. Br J Surg. 2008;95:33–49.

    Article  CAS  Google Scholar 

  32. Bokey L, Chapuis PH, Dent OF. Impact of obesity on complications after resection for rectal cancer. Colorectal Dis. 2014;16:896–906.

    Article  CAS  Google Scholar 

  33. Sugihara K, Kobayashi H, Kato T, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum. 2006;49:1663–72.

    Article  Google Scholar 

Download references

Acknowledgment

Dr. Zhifen Chen was financially supported by the National Clinical Key Specialty Construction Project (General Surgery) of China (Grant No. 2012-649) and sponsored by the Fujian Medical University Union Hospital to study at the University of Tokyo Hospital. The authors thank all members and staff of the JSCCR member institutions for collecting data for the Japanese Colorectal Cancer Registry. The authors also thank Editage (www.editage.cn) for English language editing.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Soichiro Ishihara MD, PhD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article was partially submitted to the 14th Chinese Academic Congress of Colorectal Surgery in conjunction with the International Summit of Colorectal Surgery as poster which was held in Shanghai, China, on October 15 to 17, 2021.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 26 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Z., Sasaki, K., Murono, K. et al. Oncologic Status of Obturator Lymph Node Metastases in Locally Advanced Low Rectal Cancer: A Japanese Multi-Institutional Study of 3487 Patients. Ann Surg Oncol 29, 4210–4219 (2022). https://doi.org/10.1245/s10434-022-11372-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-11372-z

Navigation